Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP‐Ribose) Polymerase Inhibitor Veliparib

Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, September 2025

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

In a multisite preclinical ischemic stroke trial, the PARP inhibitor veliparib improved neurobehavior in aging mice. #AHAJournals…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.